Harayama T , Riezman H . Understanding the diversity of membrane lipid composition . Nat Rev Mol Cell Biol . 2018 ; 19 ( 5 ): 281 - 96 .

Swirski FK , Binder CJ . Lower your cholesterol early, and stick with it! . Nat Rev Cardiol . 2025 ; 22 ( 2 ): 69 - 70 .

van Meer G , Voelker DR , Feigenson GW . Membrane lipids: where they are and how they behave . Nat Rev Mol Cell Biol . 2008 ; 9 ( 2 ): 112 - 24 .

Shimizu T . Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation . Annu Rev Pharmacol Toxicol . 2009 ; 49 ( 1 ): 123 - 50 .

Scott JD , Pawson T . Cell signaling in space and time: where proteins come together and when they’re apart . Science . 2009 ; 326 ( 5957 ): 1220 - 4 .

Thiele C , Wunderling K , Leyendecker P . Multiplexed and single cell tracing of lipid metabolism . Nat Methods . 2019 ; 16 ( 11 ): 1123 - 30 .

Yoon H , Shaw JL , Haigis MC , Greka A . Lipid metabolism in sickness and in health: emerging regulators of lipotoxicity . Mol Cell . 2021 ; 81 ( 18 ): 3708 - 30 .

Musso G , Gambino R , Cassader M . Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD) . Prog Lipid Res . 2009 ; 48 ( 1 ): 1 - 26 .

Agbu P , Carthew RW . MicroRNA-mediated regulation of glucose and lipid metabolism . Nat Rev Mol Cell Biol . 2021 ; 22 ( 6 ): 425 - 38 .

Shimano H , Sato R . SREBP-regulated lipid metabolism: convergent physiology—divergent pathophysiology . Nat Rev Endocrinol . 2017 ; 13 ( 12 ): 710 - 30 .

Zechner R , Zimmermann R , Eichmann TO , Kohlwein SD , Haemmerle G , Lass A , et al . FAT SIGNALS: lipases and lipolysis in lipid metabolism and signaling . Cell Metab . 2012 ; 15 ( 3 ): 279 - 91 .

Fitzgerald K , White S , Borodovsky A , Bettencourt BR , Strahs A , Clausen V , et al . A highly durable RNAi therapeutic inhibitor of PCSK9 . N Engl J Med . 2017 ; 376 ( 1 ): 41 - 51 .

Goga A , Stoffel M . Therapeutic RNA-silencing oligonucleotides in metabolic diseases . Nat Rev Drug Discov . 2022 ; 21 ( 6 ): 417 - 39 .

Mulder JWCM , Galema-Boers AMH , van Roeters Lennep JE . First clinical experiences with inclisiran in a real-world setting . J Clin Lipidol . 2023 ; 17 ( 6 ): 818 - 27 .

Khetarpal SA , Wang M , Khera AV . Volanesorsen, familial chylomicronemia syndrome, and thrombocytopenia . N Engl J Med . 2019 ; 381 ( 26 ): 2582 - 4 .

Majumder J , Taratula O , Minko T . Nanocarrier-based systems for targeted and site specific therapeutic delivery . Adv Drug Deliv Rev . 2019 ; 144 : 57 - 77 .

Guo Y , Cao X , Zheng X , Abbas SKJ , Li J , Tan W . Construction of nanocarriers based on nucleic acids and their applications in nanobiology delivery systems . Natl Sci Rev . 2022 ; 9 ( 5 ): nwac006 .

Wu Q , Hu Y , Yu B , Hu H , Xu FJ . Polysaccharide-based tumor microenvironment-responsive drug delivery systems for cancer therapy . J Control Release . 2023 ; 362 : 19 - 43 .

Zhou Q , Liu Q , Wang Y , Chen J , Schmid O , Rehberg M , et al . Bridging smart nanosystems with clinically relevant models and advanced imaging for precision drug delivery . Adv Sci . 2024 ; 11 ( 14 ): e2308659 .

Zhao W , Zhang L , Guo J , Xu Q , Zhang M , Liu H , et al . Intelligent nano-cage for precision delivery of CRISPR-Cas9 and ACC inhibitors to enhance antitumor cascade therapy through lipid metabolism disruption . Adv Funct Mater . 2025 ; 35 ( 13 ): 2418090 .

Walther TC , Farese RV Jr . Lipid droplets and cellular lipid metabolism . Annu Rev Biochem . 2012 ; 81 : 687 - 714 .

Cheng C , Geng F , Cheng X , Guo D . Lipid metabolism reprogramming and its potential targets in cancer . Cancer Commun (Lond) . 2018 ; 38 ( 1 ): 27 .

Terry AR , Hay N . Emerging targets in lipid metabolism for cancer therapy . Trends Pharmacol Sci . 2024 ; 45 ( 6 ): 537 - 51 .

Hirsch D , Stahl A , Lodish HF . A family of fatty acid transporters conserved from mycobacterium to man . Proc Natl Acad Sci USA . 1998 ; 95 ( 15 ): 8625 - 9 .

Liang K , Dai JY . Progress of potential drugs targeted in lipid metabolism research . Front Pharmacol . 2022 ; 13 : 1067652 .

Wang J , Guo H , Zheng LF , Li P , Zhao TJ . Context-specific fatty acid uptake is a finely-tuned multi-level effort . Trends Endocrinol Metab . 2025 ; 36 ( 6 ): 577 - 90 .

Coburn CT , Jr Knapp FF , Febbraio M , Beets AL , Silverstein RL , Abumrad NA . Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice . J Biol Chem . 2000 ; 275 ( 42 ): 32523 - 9 .

Thaler H . Pathology of viral hepatitis and its sequelae . Bull N Y Acad Med . 1975 ; 51 ( 4 ): 481 - 90 .

Hames KC , Vella A , Kemp BJ , Jensen MD . Free fatty acid uptake in humans with CD36 deficiency . Diabetes . 2014 ; 63 ( 11 ): 3606 - 14 .

Wang J , Hao JW , Wang X , Guo HL , Sun HH , Lai XY , et al . DHHC4 and DHHC5 facilitate fatty acid uptake by palmitoylating and targeting CD36 to the plasma membrane . Cell Rep . 2019 ; 26 ( 1 ): 209 - 21 .

Hao JW , Wang J , Guo H , Zhao YY , Sun HH , Li YF , et al . CD36 facilitates fatty acid uptake by dynamic palmitoylation-regulated endocytosis . Nat Commun . 2020 ; 11 ( 1 ): 4765 .

Bonen A , Luiken JJFP , Arumugam Y , Glatz JFC , Tandon NN . Acute regulation of fatty acid uptake involves the cellular redistribution of fatty acid translocase . J Biol Chem . 2000 ; 275 ( 19 ): 14501 - 8 .

Schwenk RW , Holloway GP , Luiken JJ , Bonen A , Glatz JF . Fatty acid transport across the cell membrane: regulation by fatty acid transporters . Prostaglandins Leukot Essent Fatty Acids . 2010 ; 82 ( 4-6 ): 149 - 54 .

Kampf JP , Kleinfeld AM . Is membrane transport of FFA mediated by lipid, protein, or both? An unknown protein mediates free fatty acid transport across the adipocyte plasma membrane . Physiology Bethesda . 2007 ; 22 : 7 - 14 .

Bonen A , Chabowski A , Luiken JJFP , Glatz JF . Is membrane transport of FFA mediated by lipid, protein, or both? Mechanisms and regulation of protein-mediated cellular fatty acid uptake: molecular, biochemical, and physiological evidence . Physiology Bethesda . 2007 ; 22 : 15 - 29 .

Chabowski A , Górski J , Luiken JJFP , Glatz JFC , Bonen A . Evidence for concerted action of FAT/CD36 and FABPpm to increase fatty acid transport across the plasma membrane . Prostaglandins Leukot Essent Fatty Acids . 2007 ; 77 ( 5-6 ): 345 - 53 .

Chkourko Gusky H , Diedrich J , MacDougald OA , Podgorski I . Omentum and bone marrow: how adipocyte-rich organs create tumour microenvironments conducive for metastatic progression . Obes Rev . 2016 ; 17 ( 11 ): 1015 - 29 .

Pohl J , Ring A , Ehehalt R , Herrmann T , Stremmel W . New concepts of cellular fatty acid uptake: role of fatty acid transport proteins and of caveolae . Proc Nutr Soc . 2004 ; 63 ( 2 ): 259 - 62 .

Gemmink A , Daemen S , Kuijpers HJH , Schaart G , Duimel H , Lopez-Iglesias C , et al . Super-resolution microscopy localizes perilipin 5 at lipid droplet-mitochondria interaction sites and at lipid droplets juxtaposing to perilipin 2 . Biochim Biophys Acta (BBA) . 2018 ; 1863 ( 11 ): 1423 - 32 .

Ouyang Q , Chen Q , Ke S , Ding L , Yang X , Rong P , et al . Rab8a as a mitochondrial receptor for lipid droplets in skeletal muscle . Dev Cell . 2023 ; 58 ( 4 ): 289 - 305.e6 .

Miner GE , So CM , Edwards W , Ragusa JV , Wine JT , Gutierrez DW , et al . PLIN5 interacts with FATP4 at membrane contact sites to promote lipid droplet-to-mitochondria fatty acid transport . Dev Cell . 2023 ; 58 ( 14 ): 1250 - 65 .

Xiao J , Dong LW , Liu S , Meng FH , Xie C , Lu XY , et al . Bile acids-mediated intracellular cholesterol transport promotes intestinal cholesterol absorption and NPC1L1 recycling . Nat Commun . 2023 ; 14 ( 1 ): 6469 .

Hu M , Yang F , Huang Y , You X , Liu D , Sun S , et al . Structural insights into the mechanism of human NPC1L1-mediated cholesterol uptake . Sci Adv . 2021 ; 7 ( 29 ): eabg3188 .

Ferrari A , Whang E , Xiao X , Kennelly JP , Romartinez-Alonso B , Mack JJ , et al . Aster-dependent nonvesicular transport facilitates dietary cholesterol uptake . Science . 2023 ; 382 ( 6671 ): eadf0966 .

Ko CW , Qu J , Black DD , Tso P . Regulation of intestinal lipid metabolism: current concepts and relevance to disease . Nat Rev Gastroenterol Hepatol . 2020 ; 17 ( 3 ): 169 - 83 .

Luo J , Yang HY , Song BL . Mechanisms and regulation of cholesterol homeostasis . Nat Rev Mol Cell Bio . 2020 ; 21 ( 4 ): 225 - 45 .

Zelcer N , Hong C , Boyadjian R , Tontonoz P . LXR regulates cholesterol uptake through idol-dependent ubiquitination of the LDL receptor . Science . 2009 ; 325 ( 5936 ): 100 - 4 .

Lagace TA . PCSK9 and LDLR degradation: regulatory mechanisms in circulation and in cells . Curr Opin Lipidol . 2014 ; 25 ( 5 ): 387 - 93 .

Menendez JA , Lupu R . Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis . Nat Rev Cancer . 2007 ; 7 ( 10 ): 763 - 77 .

Hanahan D , Weinberg RA . Hallmarks of cancer: the next generation . Cell . 2011 ; 144 ( 5 ): 646 - 74 .

Metallo CM , Gameiro PA , Bell EL , Mattaini KR , Yang J , Hiller K , et al . Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia . Nature . 2011 ; 481 ( 7381 ): 380 - 4 .

Ito H , Nakamae I , Kato J , Yoneda-Kato N . Stabilization of fatty acid synthesis enzyme acetyl-CoA carboxylase 1 suppresses acute myeloid leukemia development . J Clin Invest . 2021 ; 131 ( 12 ): e141529 .

Ameer F , Scandiuzzi L , Hasnain S , Kalbacher H , Zaidi N . De novo lipogenesis in health and disease . Metabolism . 2014 ; 63 ( 7 ): 895 - 902 .

Schug ZT , Peck B , Jones DT , Zhang Q , Grosskurth S , Alam IS , et al . Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell growth under metabolic stress . Cancer Cell . 2015 ; 27 ( 1 ): 57 - 71 .

Kuna RS , Kumar A , Wessendorf-Rodriguez KA , Galvez H , Green CR , McGregor GH , et al . Inter-organelle cross-talk supports acetyl-coenzyme A homeostasis and lipogenesis under metabolic stress . Sci Adv . 2023 ; 9 ( 18 ): eadf0138 .

Scott JS , Nassar ZD , Swinnen JV , Butler LM . Monounsaturated fatty acids: key regulators of cell viability and intracellular signaling in cancer . Mol Cancer Res . 2022 ; 20 ( 9 ): 1354 - 64 .

Lin R , Tao R , Gao X , Li T , Zhou X , Guan KL , et al . Acetylation stabilizes ATP-citrate lyase to promote lipid biosynthesis and tumor growth . Mol Cell . 2013 ; 51 ( 4 ): 506 - 18 .

Migita T , Narita T , Nomura K , Miyagi E , Inazuka F , Matsuura M , et al . ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer . Cancer Res . 2008 ; 68 ( 20 ): 8547 - 54 .

Lee JV , Carrer A , Shah S , Snyder NW , Wei S , Venneti S , et al . Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation . Cell Metab . 2014 ; 20 ( 2 ): 306 - 19 .

Korobkina ED , Calejman CM , Haley JA , Kelly ME , Li H , Gaughan M , et al . Brown fat ATP-citrate lyase links carbohydrate availability to thermogenesis and guards against metabolic stress . Nat Metab . 2024 ; 6 ( 11 ): 2187 - 202 .

Yoshimura Y , Araki A , Maruta H , Takahashi Y , Yamashita H . Molecular cloning of rat acss3 and characterization of mammalian propionyl-CoA synthetase in the liver mitochondrial matrix . J Biochem . 2017 ; 161 ( 3 ): 279 - 89 .

Ling R , Chen G , Tang X , Liu N , Zhou YP , Chen DY . Acetyl-CoA synthetase 2(ACSS2): a review with a focus on metabolism and tumor development . Discov Oncol . 2022 ; 13 ( 1 ): 58 .

Mashimo T , Pichumani K , Vemireddy V , Hatanpaa KJ , Singh DK , Sirasanagandla S , et al . Acetate is a bioenergetic substrate for human glioblastoma and brain metastases . Cell . 2014 ; 159 ( 7 ): 1603 - 14 .

Ikeda Y , Yamamoto J , Okamura M , Fujino T , Takahashi S , Takeuchi K , et al . Transcriptional regulation of the murine acetyl-CoA synthetase 1 gene through multiple clustered binding sites for sterol regulatory element-binding proteins and a single neighboring site for Sp1 . J Biol Chem . 2001 ; 276 ( 36 ): 34259 - 69 .

Sabari BR , Tang Z , Huang H , Yong-Gonzalez V , Molina H , Kong HE , et al . Intracellular crotonyl-CoA stimulates transcription through p300-catalyzed histone crotonylation . Mol Cell . 2015 ; 58 ( 2 ): 203 - 15 .

Huang WB , Hu WM , Cai LL , Zeng GR , Fang WT , Dai XM , et al . Acetate supplementation produces antidepressant-like effect via enhanced histone acetylation . J Affect Disord . 2021 ; 281 : 51 - 60 .

Deja S , Fletcher JA , Kim CW , Kucejova B , Fu XR , Mizerska M , et al . Hepatic malonyl-CoA synthesis restrains gluconeogenesis by suppressing fat oxidation, pyruvate carboxylation, and amino acid availability . Cell Metab . 2024 ; 36 ( 5 ): 1088 - 1104.e12 .

Lally JSV , Ghoshal S , De Peralta DK , Moaven O , Wei L , Masia R , et al . Inhibition of acetyl-CoA carboxylase by phosphorylation or the inhibitor ND-654 suppresses lipogenesis and hepatocellular carcinoma . Cell Metab . 2019 ; 29 ( 1 ): 174 - 82 .

Zhou FY , Zhang YY , Zhu YY , Zhou Q , Shi YG , Hu Q . Filament structures unveil the dynamic organization of human acetyl-CoA carboxylase . Sci Adv . 2024 ; 10 ( 41 ): eado4880 .

Ueda K , Nakatsu Y , Yamamotoya T , Ono H , Inoue Y , Inoue MK , et al . Prolyl isomerase Pin1 binds to and stabilizes acetyl CoA carboxylase 1 protein, thereby supporting cancer cell proliferation . Oncotarget . 2019 ; 10 ( 17 ): 1637 - 48 .

Koundouros N , Poulogiannis G . Reprogramming of fatty acid metabolism in cancer . Br J Cancer . 2020 ; 122 ( 1 ): 4 - 22 .

Xu W , Hu X , Anwaier A , Wang J , Liu W , Tian X , et al . Fatty acid synthase correlates with prognosis-related abdominal adipose distribution and metabolic disorders of clear cell renal cell carcinoma . Front Mol Biosci . 2020 ; 7 : 610229 .

Wang L , Zhu H , Shi Z , Chen B , Huang H , Lin G , et al . MK8722 initiates early-stage autophagy while inhibiting late-stage autophagy via FASN-dependent reprogramming of lipid metabolism . Theranostics . 2024 ; 14 ( 1 ): 75 - 95 .

Lu F , Ye M , Hu C , Chen J , Yan L , Gu D , et al . FABP5 regulates lipid metabolism to facilitate pancreatic neuroendocrine neoplasms progression via FASN mediated Wnt/β-catenin pathway . Cancer Sci . 2023 ; 114 ( 9 ): 3553 - 67 .

Lan T , Geng XJ , Zhang SJ , Zeng XX , Ying JJ , Xu Y , et al . Si-Ni-San inhibits hepatic Fasn expression and lipid accumulation in MAFLD mice through AMPK/p300/SREBP-1c axis . Phytomedicine . 2024 ; 123 : 155209 .

Wei W , Qin B , Wen W , Zhang B , Luo H , Wang Y , et al . FBXW7β loss-offunction enhances FASN-mediated lipogenesis and promotes colorectal cancer growth . Signal Transduct Target Ther . 2023 ; 8 ( 1 ): 187 .

Gong Z , Zhu J , Chen J , Feng F , Zhang H , Zhang Z , et al . CircRREB1 mediates lipid metabolism related senescent phenotypes in chondrocytes through FASN post-translational modifications . Nat Commun . 2023 ; 14 ( 1 ): 5242 .

Snaebjornsson MT , Janaki-Raman S , Schulze A . Greasing the wheels of the cancer machine: the role of lipid metabolism in cancer . Cell Metab . 2020 ; 31 ( 1 ): 62 - 76 .

Pinkham K , Park DJ , Hashemiaghdam A , Kirov AB , Adam I , Rosiak K , et al . Stearoyl CoA desaturase is essential for regulation of endoplasmic reticulum homeostasis and tumor growth in glioblastoma cancer stem cells . Stem Cell Reports . 2019 ; 12 ( 4 ): 712 - 27 .

Tracz-Gaszewska Z , Dobrzyn P . Stearoyl-CoA desaturase 1 as a therapeutic target for the treatment of cancer . Cancers . 2019 ; 11 ( 7 ): 948 .

Sen U , Coleman C , Sen T . Stearoyl coenzyme A desaturase-1: multitasker in cancer, metabolism, and ferroptosis . Trends Cancer . 2023 ; 9 ( 6 ): 480 - 9 .

Aljohani A , Khan MI , Bonneville A , Guo C , Jeffery J , O’Neill L , et al . Hepatic stearoyl CoA desaturase 1 deficiency increases glucose uptake in adipose tissue partially through the PGC-1α-FGF21 axis in mice . J Biol Chem . 2019 ; 294 ( 51 ): 19475 - 85 .

Hyun CK , Kim ED , Flowers MT , Liu X , Kim E , Strable M , et al . Adiposespecific deletion of stearoyl-CoA desaturase 1 up-regulates the glucose transporter GLUT1 in adipose tissue . Biochem Biophys Res Commun . 2010 ; 399 ( 4 ): 480 - 6 .

ALJohani AM , Syed DN , Ntambi JM . Insights into stearoyl-CoA desaturase-1 regulation of systemic metabolism . Trends Endocrinol Metab . 2017 ; 28 ( 12 ): 831 - 42 .

Tibori K , Orosz G , Zámbó V , Szelényi P , Sarnyai F , Tamási V , et al . Molecular mechanisms underlying the elevated expression of a potentially type 2 diabetes mellitus associated SCD1 variant . Int J Mol Sci . 2022 ; 23 ( 11 ): 6221 .

Liscum L , Finer-Moore J , Stroud RM , Luskey KL , Brown MS , Goldstein JL . Domain structure of 3-hydroxy-3-methylglutaryl coenzyme A reductase, a glycoprotein of the endoplasmic reticulum . J Biol Chem . 1985 ; 260 ( 1 ): 522 - 30 .

Cerqueira NMFSA , Oliveira EF , Gesto DS , Santos-Martins D , Moreira C , Moorthy HN , et al . Cholesterol biosynthesis: a mechanistic overview . Biochemistry . 2016 ; 55 ( 39 ): 5483 - 506 .

Luo W , Adamska JZ , Li C , Verma R , Liu Q , Hagan T , et al . SREBP signaling is essential for effective B cell responses . Nat Immunol . 2023 ; 24 ( 2 ): 337 - 48 .

Xu M , Jiang SY , Tang S , Zhu M , Hu Y , Li J , et al . Nuclear SREBP2 condensates regulate the transcriptional activation of lipogenic genes and cholesterol homeostasis . Nat Metab . 2025 ; 7 ( 5 ): 1034 - 51 .

Howe V , Sharpe LJ , Prabhu AV , Brown AJ . New insights into cellular cholesterol acquisition: promoter analysis of human HMGCR and SQLE, two key control enzymes in cholesterol synthesis . Biochim Biophys Acta (BBA) . 2017 ; 1862 ( 7 ): 647 - 57 .

Lu XY , Shi XJ , Hu A , Wang JQ , Ding Y , Jiang W , et al . Feeding induces cholesterol biosynthesis via the mTORC1-USP20-HMGCR axis . Nature . 2020 ; 588 ( 7838 ): 479 - 84 .

Sun H , Li L , Li W , Yang F , Zhang Z , Liu Z , et al . p53 transcriptionally regulates SQLE to repress cholesterol synthesis and tumor growth . EMBO Rep . 2021 ; 22 ( 10 ): e52537 .

Jun SY , Brown AJ , Chua NK , Yoon JY , Lee JJ , Yang JO , et al . Reduction of squalene epoxidase by cholesterol accumulation accelerates colorectal cancer progression and metastasis . Gastroenterology . 2021 ; 160 ( 4 ): 1194 - 207.e28 .

Li Z , Liu H , Luo X . Lipid droplet and its implication in cancer progression . Am J Cancer Res . 2020 ; 10 ( 12 ): 4112 - 22 .

Petan T . Lipid droplets in cancer . Rev Physiol Biochem Pharmacol . 2023 ; 185 : 53 - 86 .

Chandrasekaran P , Weiskirchen S , Weiskirchen R . Perilipins: a family of five fat-droplet storing proteins that play a significant role in fat homeostasis . J Cell Biochem . 2024 ; 125 ( 6 ): e30579 .

Thiam AR , Ikonen E . Lipid droplet nucleation . Trends Cell Biol . 2021 ; 31 ( 2 ): 108 - 18 .

Hegaard FV , Klenow MB , Simonsen AC . Lens nucleation and droplet budding in a membrane model for lipid droplet biogenesis . Langmuir . 2022 ; 38 ( 30 ): 9247 - 56 .

Apte MS , Joshi AS . Membrane shaping proteins, lipids, and cytoskeleton: recipe for nascent lipid droplet formation . BioEssays . 2022 ; 44 ( 9 ): e2200038 .

Jin HR , Wang J , Wang ZJ , Xi MJ , Xia BH , Deng K , et al . Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics . J Hematol Oncol . 2023 ; 16 ( 1 ): 103 .

Han L , Huang D , Wu S , Liu S , Wang C , Sheng Y , et al . Lipid droplet-associated lncRNA LIPTER preserves cardiac lipid metabolism . Nat Cell Biol . 2023 ; 25 ( 7 ): 1033 - 46 .

Grabner GF , Xie H , Schweiger M , Zechner R . Lipolysis: cellular mechanisms for lipid mobilization from fat stores . Nat Metab . 2021 ; 3 ( 11 ): 1445 - 65 .

Zimmermann R , Strauss JG , Haemmerle G , Schoiswohl G , Birner-Gruenberger R , Riederer M , et al . Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase . Science . 2004 ; 306 ( 5700 ): 1383 - 6 .

Grumet L , Eichmann TO , Taschler U , Zierler KA , Leopold C , Moustafa T , et al . Lysosomal acid lipase hydrolyzes retinyl ester and affects retinoid turnover . J Biol Chem . 2016 ; 291 ( 34 ): 17977 - 87 .

Sheriff S , Du H , Grabowski GA . Characterization of lysosomal acid lipase by site-directed mutagenesis and heterologous expression . J Biol Chem . 1995 ; 270 ( 46 ): 27766 - 72 .

Warner TG , Dambach LM , Shin JH , O’Brien JS . Purification of the lysosomal acid lipase from human liver and its role in lysosomal lipid hydrolysis . J Biol Chem . 1981 ; 256 ( 6 ): 2952 - 7 .

Ding L , Huwyler F , Long F , Yang W , Binz J , Wernlé K , et al . Glucose controls lipolysis through Golgi PtdIns4P-mediated regulation of ATGL . Nat Cell Biol . 2024 ; 26 ( 4 ): 552 - 66 .

Shiau MY , Chuang PH , Yang CP , Hsiao CW , Chang SW , Chang KY , et al . Mechanism of interleukin-4 reducing lipid deposit by regulating hormone-sensitive lipase . Sci Rep . 2019 ; 9 ( 1 ): 11974 .

Demine S , Tejerina S , Bihin B , Thiry M , Reddy N , Renard P , et al . Mild mitochondrial uncoupling induces HSL/ATGL-independent lipolysis relying on a form of autophagy in 3T3-L1 adipocytes . J Cell Physiol . 2018 ; 233 ( 2 ): 1247 - 65 .

Huang X , Huang X , Guo H , Li J , Zhou C , Huang Y , et al . Intermittent hypoxia-induced METTL3 downregulation facilitates MGLL-mediated lipolysis of adipocytes in OSAS . Cell Death Discov . 2022 ; 8 ( 1 ): 352 .

Tsai TH , Chen E , Li L , Saha P , Lee HJ , Huang LS , et al . The constitutive lipid droplet protein PLIN2 regulates autophagy in liver . Autophagy . 2017 ; 13 ( 7 ): 1130 - 44 .

Leong I . Muscle circadian clock regulates lipid storage . Nat Rev Endocrinol . 2018 ; 14 ( 10 ): 563 .

Petrenko V , Sinturel F , Riezman H , Dibner C . Lipid metabolism around the body clocks . Prog Lipid Res . 2023 ; 91 : 101235 .

Carracedo A , Cantley LC , Pandolfi PP . Cancer metabolism: fatty acid oxidation in the limelight . Nat Rev Cancer . 2013 ; 13 ( 4 ): 227 - 32 .

Zaugg K , Yao Y , Reilly PT , Kannan K , Kiarash R , Mason J , et al . Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress . Genes Dev . 2011 ; 25 ( 10 ): 1041 - 51 .

Cheng X , Geng F , Pan M , Wu X , Zhong Y , Wang C , et al . Targeting DGAT1 ameliorates glioblastoma by increasing fat catabolism and oxidative stress . Cell Metab . 2020 ; 32 ( 2 ): 229 - 42.e8 .

Minokoshi Y , Kim YB , Peroni OD , Fryer LG , Muller C , Carling D , et al . Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase . Nature . 2002 ; 415 ( 6869 ): 339 - 43 .

Peng Y , Qi Z , Xu Y , Yang X , Cui Y , Sun Q . AMPK and metabolic disorders: the opposite roles of dietary bioactive components and food contaminants . Food Chem . 2024 ; 437 ( 1 ): 137784 .

Kulig W , Cwiklik L , Jurkiewicz P , Rog T , Vattulainen I . Cholesterol oxidation products and their biological importance . Chem Phys Lipids . 2016 ; 199 : 144 - 60 .

Saito Y , Noguchi N , Niki E . Cholesterol is more readily oxidized than phospholipid linoleates in cell membranes to produce cholesterol hydroperoxides . Free Radic Biol Med . 2024 ; 211 : 89 - 95 .

Wang Y , Zhang J , Chen J , Wang D , Yu Y , Qiu P , et al . Ch25h and 25-HC prevent liver steatosis through regulation of cholesterol metabolism and inflammation . Acta Biochim Biophys Sin . 2022 ; 54 ( 4 ): 504 - 13 .

Sun M , Chen Q , Ren Y , Zhuo Y , Xu S , Rao H , et al . CoNiCoNC tumor therapy by two-ways producing H(2)O(2) to aggravate energy metabolism, chemokinetics, and ferroptosis . J Colloid Interface Sci . 2025 ; 678 : 925 - 37 .

Zaborowska-Mazurkiewicz M , Bizoń T , Matyszewska D , Fontaine P , Bilewicz R . Oxidation of lipid membrane cholesterol by cholesterol oxidase and its effects on raft model membrane structure . Colloids Surf B Biointerfaces . 2025 ; 245 : 114191 .

Kobayashi J , Kawakubo M , Fujii C , Arisaka N , Miyashita M , Sato Y , et al . Cholestenone functions as an antibiotic against Helicobacter pylori by inhibiting biosynthesis of the cell wall component CGL . Proc Natl Acad Sci U S A . 2021 ; 118 ( 16 ): e2016469118 .

Yan J , Horng T . Lipid metabolism in regulation of macrophage functions . Trends Cell Biol . 2020 ; 30 ( 12 ): 979 - 89 .

Faubert B , Solmonson A , DeBerardinis RJ . Metabolic reprogramming and cancer progression . Science . 2020 ; 368 ( 6487 ): eaaw5473 .

Yang K , Wang X , Song C , He Z , Wang R , Xu Y , et al . The role of lipid metabolic reprogramming in tumor microenvironment . Theranostics . 2023 ; 13 ( 6 ): 1774 - 808 .

Zhou X , Su M , Lu J , Li D , Niu X , Wang Y . CD36: the bridge between lipids and tumors . Molecules . 2024 ; 29 ( 2 ): 531 .

Zhang C , Liao Y , Liu P , Du Q , Liang Y , Ooi S , et al . FABP5 promotes lymph node metastasis in cervical cancer by reprogramming fatty acid metabolism . Theranostics . 2020 ; 10 ( 15 ): 6561 - 80 .

Veglia F , Tyurin VA , Blasi M , De Leo A , Kossenkov AV , Donthireddy L , et al . Fatty acid transport protein 2 reprograms neutrophils in cancer . Nature . 2019 ; 569 ( 7754 ): 73 - 8 .

Wen J , Min X , Shen M , Hua Q , Han Y , Zhao L , et al . ACLY facilitates colon cancer cell metastasis by CTNNB1 . J Exp Clin Cancer Res . 2019 ; 38 ( 1 ): 401 .

Wang L , Li C , Song Y , Yan Z . Inhibition of carnitine palmitoyl transferase 1A-induced fatty acid oxidation suppresses cell progression in gastric cancer . Arch Biochem Biophys . 2020 ; 696 : 108664 .

Nimmakayala RK , Leon F , Rachagani S , Rauth S , Nallasamy P , Marimuthu S , et al . Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma . Oncogene . 2021 ; 40 ( 1 ): 215 - 31 .

Zhang Q , Wang H , Mao C , Sun M , Dominah G , Chen L , et al . Fatty acid oxidation contributes to IL-1β secretion in M2 macrophages and promotes macrophage-mediated tumor cell migration . Mol Immunol . 2018 ; 94 : 27 - 35 .

Ma Q , Meng Z , Meng Y , Liu R , Lu Z . A moonlighting function of choline kinase alpha 2 in the initiation of lipid droplet lipolysis in cancer cells . Cancer Commun . 2021 ; 41 ( 10 ): 933 - 6 .

Dey P , Kimmelman AC , DePinho RA . Metabolic codependencies in the tumor microenvironment . Cancer Discov . 2021 ; 11 ( 5 ): 1067 - 81 .

Sun Z , Zhang L , Liu L . Reprogramming the lipid metabolism of dendritic cells in tumor immunomodulation and immunotherapy . Biomed Pharmacother . 2023 ; 167 : 115574 .

Xie Q , Zeng Y , Zhang X , Yu F . The significance of lipid metabolism reprogramming of tumor-associated macrophages in hepatocellular carcinoma . Cancer Immunol Immunother . 2024 ; 73 ( 9 ): 171 .

Gong J , Lin Y , Zhang H , Liu C , Cheng Z , Yang X , et al . Reprogramming of lipid metabolism in cancer-associated fibroblasts potentiates migration of colorectal cancer cells . Cell Death Dis . 2020 ; 11 ( 4 ): 267 .

Brown OI , Drozd M , McGowan H , Giannoudi M , Conning-Rowland M , Gierula J , et al . Relationship among diabetes, obesity, and cardiovascular disease phenotypes: a UK biobank cohort study . Diabetes Care . 2023 ; 46 ( 8 ): 1531 - 40 .

Mela V , Ruiz-Limón P , Balongo M , Motahari Rad H , Subiri-Verdugo A , Gonzalez-Jimenez A , et al . Mitochondrial homeostasis in obesity-related hypertriglyceridemia . J Clin Endocrinol Metab . 2022 ; 107 ( 8 ): 2203 - 15 .

Kjellmo CA , Karlsson H , Nestvold TK , Ljunggren S , Cederbrant K , Marcusson-Ståhl M , et al . Bariatric surgery improves lipoprotein profile in morbidly obese patients by reducing LDL cholesterol, apoB, and SAA/PON1 ratio, increasing HDL cholesterol, but has no effect on cholesterol efflux capacity . J Clin Lipidol . 2018 ; 12 ( 1 ): 193 - 202 .

Moata H . Desordre lipidique et obésité: les relations sont-elles si étroites? . Ann Endocrinol (Paris) . 2018 ; 79 ( 4 ): 519 .

Hussein M , Mirza I , Morsy M , Mostafa A , Hassan C , Masrur M , et al . Comparison of adiposomal lipids between obese and non-obese individuals . Metabolites . 2024 ; 14 ( 8 ): 464 .

Wagner N , Wagner KD . The role of PPARs in disease . Cells . 2020 ; 9 ( 11 ): 2367 .

Saito K , Sekiya M , Kainoh K , Yoshino R , Hayashi A , Han SI , et al . Obesity-induced metabolic imbalance allosterically modulates CtBP2 to inhibit PPAR-alpha transcriptional activity . J Biol Chem . 2023 ; 299 ( 7 ): 104890 .

Foretz M , Guigas B , Bertrand L , Pollak M , Viollet B . Metformin: from mechanisms of action to therapies . Cell Metab . 2014 ; 20 ( 6 ): 953 - 66 .

Rozovski U , Harris DM , Li P , Liu Z , Jain P , Ferrajoli A , et al . STAT3-activated CD36 facilitates fatty acid uptake in chronic lymphocytic leukemia cells . Oncotarget . 2018 ; 9 ( 30 ): 21268 - 80 .

Christiaens V , Van Hul M , Lijnen HR , Scroyen I . CD36 promotes adipocyte differentiation and adipogenesis . Biochim Biophys Acta . 2012 ; 1820 ( 7 ): 949 - 56 .

Su T , Huang C , Yang C , Jiang T , Su J , Chen M , et al . Apigenin inhibits STAT3/CD36 signaling axis and reduces visceral obesity . Pharmacol Res . 2020 ; 152 : 104586 .

Finsterer J , Scorza FA , Fiorini AC , Scorza CA . MEGDEL syndrome . Pediatr Neurol . 2020 ; 110 : 25 - 9 .

Du M , Li X , Xiao F , Fu Y , Shi Y , Guo S , et al . Serine active site containing protein 1 depletion alters lipid metabolism and protects against high fat diet-induced obesity in mice . Metabolism . 2022 ; 134 : 155244 .

Koh KK . Role of adiponectin: Important or null? . J Am Coll Cardiol . 2017 ; 69 ( 11 ): 1518 .

Yamauchi T , Kamon J , Minokoshi Y , Ito Y , Waki H , Uchida S , et al . Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase . Nat Med . 2002 ; 8 ( 11 ): 1288 - 95 .

Wang Y , Lam KSL , Xu A . Adiponectin as a therapeutic target for obesity-related metabolic and cardiovascular disorders . Drug Dev Res . 2006 ; 67 ( 8 ): 677 - 86 .

Xu A , Wang H , Hoo RLC , Sweeney G , Vanhoutte PM , Wang Y , et al . Selective elevation of adiponectin production by the natural compounds derived from a medicinal herb alleviates insulin resistance and glucose intolerance in obese mice . Endocrinology . 2009 ; 150 ( 2 ): 625 - 33 .

Shou JW , Shaw PC . Berberine reduces lipid accumulation in obesity via mediating transcriptional function of PPARδ . Int J Mol Sci . 2023 ; 24 ( 14 ): 11600 .

Bersoux S , Byun TH , Chaliki SS , Poole KG . Pharmacotherapy for obesity: What you need to know . Cleve Clin J Med . 2017 ; 84 ( 12 ): 951 - 8 .

Ard J , Fitch A , Fruh S , Herman L . Weight loss and maintenance related to the mechanism of action of glucagon-like peptide 1 receptor agonists . Adv Ther . 2021 ; 38 ( 6 ): 2821 - 39 .

Buyukhatipoglu H . A possibly overlooked side effect of Orlistat: gastroesophageal reflux disease . J Natl Med Assoc . 2008 ; 100 ( 10 ): 1207 .

Furse S . Lipid metabolism is dysregulated in a mouse model of diabetes . Metabolomics . 2022 ; 18 ( 6 ): 36 .

Eid S , Sas KM , Abcouwer SF , Feldman EL , Gardner TW , Pennathur S , et al . New insights into the mechanisms of diabetic complications: role of lipids and lipid metabolism . Diabetologia . 2019 ; 62 ( 9 ): 1539 - 49 .

Han YZ , Du BX , Zhu XY , Wang YZ , Zheng HJ , Liu WJ . Lipid metabolism disorder in diabetic kidney disease . Front Endocrinol (Lausanne) . 2024 ; 15 : 1336402 .

Busik JV . Lipid metabolism dysregulation in diabetic retinopathy . J Lipid Res . 2021 ; 62 : 100017 .

Song LJ , Han R , Yin H , Li J , Zhang Y , Wang J , et al . Sphingolipid metabolism plays a key role in diabetic peripheral neuropathy . Metabolomics . 2022 ; 18 ( 6 ): 32 .

Boutari C , DeMarsilis A , Mantzoros CS . Obesity and diabetes . Diabetes Res Clin Pract . 2023 ; 202 : 110773 .

Ke Q , Xiao Y , Liu D , Shi C , Shen R , Qin S , et al . PPARα/δ dual agonist H11 alleviates diabetic kidney injury by improving the metabolic disorders of tubular epithelial cells . Biochem Pharmacol . 2024 ; 222 : 116076 .

Holm LJ , Krogvold L , Hasselby JP , Kaur S , Claessens LA , Russell MA , et al . Abnormal islet sphingolipid metabolism in type 1 diabetes . Diabetologia . 2018 ; 61 ( 7 ): 1650 - 61 .

Holm LJ , Mønsted M , Haupt-Jorgensen M , Buschard K . PPARs and the development of type 1 diabetes . PPAR Res . 2020 ; 2020 : 6198628 .

Yang J , Zhou Y , Guan Y . PPARγ as a therapeutic target in diabetic nephropathy and other renal diseases . Curr Opin Nephrol Hypertens . 2012 ; 21 ( 1 ): 97 - 105 .

Yan R , Wang Y , Shi M , Xiao Y , Liu L , Liu L , et al . Regulation of PTEN/Akt/FAK pathways by PPARγ impacts on fibrosis in diabetic nephropathy . J Cell Biochem . 2019 ; 120 ( 5 ): 6998 - 7014 .

Kim Y , Park CW . Mechanisms of adiponectin action: implication of adiponectin receptor agonism in diabetic kidney disease . Int J Mol Sci . 2019 ; 20 ( 7 ): 1782 .

Kim HS , Jo J , Lim JE , Yun YD , Baek SJ , Lee TY , et al . Adiponectin as predictor for diabetes among pre-diabetic groups . Endocrine . 2013 ; 44 ( 2 ): 411 - 8 .

Banerjee A , Khemka VK , Roy D , Poddar J , Roy TKS , Karnam SA . Role of serum adiponectin and vitamin D in prediabetes and diabetes mellitus . Can J Diabetes . 2017 ; 41 ( 3 ): 259 - 65 .

Deng H , Ai M , Cao Y , Cai L , Guo X , Yang X , et al . Potential protective function of adiponectin in diabetic retinopathy . Ophthalmol Ther . 2023 ; 12 ( 3 ): 1519 - 34 .

Tang C , Deng X , Qu J , Miao Y , Tian L , Zhang M , et al . Fenofibrate attenuates renal tubular cell apoptosis by up-regulating MCAD in diabetic kidney disease . Drug Des Devel Ther . 2023 ; 17 : 1503 - 14 .

Holm LJ , Haupt-Jorgensen M , Giacobini JD , Hasselby JP , Bilgin M , Buschard K . Fenofibrate increases very-long-chain sphingolipids and improves blood glucose homeostasis in NOD mice . Diabetologia . 2019 ; 62 ( 12 ): 2262 - 72 .

Ma C , Hua Y , Yang S , Zhao Y , Zhang W , Miao Y , et al . Wogonin attenuates atherosclerosis via KLF11-mediated suppression of PPARα-YAP1-driven glycolysis and enhancement of ABCA1/G1-mediated cholesterol efflux . Adv Sci . 2025 ; 12 ( 23 ): e2500610 .

Henry D , Baugé E , Hennuyer N , Ory K , Derudas B , Vallez E , et al . Anti-inflammatory, but not lipid-lowering, activity of hepatocyte PPARα improves atherosclerosis in Ldlr-deficient mice . Sci Transl Med . 2025 ; 17 ( 800 ): eadj8192 .

van Bilsen M , van Nieuwenhoven FA . PPARs as therapeutic targets in cardiovascular disease . Expert Opin Ther Targets . 2010 ; 14 ( 10 ): 1029 - 45 .

Dutka M , Zimmer K , Ćwiertnia M , Ilczak T , Bobiński R . The role of PCSK9 in heart failure and other cardiovascular diseases-mechanisms of action beyond its effect on LDL cholesterol . Heart Fail Rev . 2024 ; 29 ( 5 ): 917 - 37 .

Guo Y , Yan B , Gui Y , Tang Z , Tai S , Zhou S , et al . Physiology and role of PCSK9 in vascular disease: potential impact of localized PCSK9 in vascular wall . J Cell Physiol . 2021 ; 236 ( 4 ): 2333 - 51 .

Grejtakova D , Boronova I , Bernasovska J , Bellosta S . PCSK9 and lipid metabolism: genetic variants, current therapies, and cardiovascular outcomes . Cardiovasc Drugs Ther . 2024 .

Schmidt AF , Hunt NB , Gordillo-Marañón M , Charoen P , Drenos F , Kivimaki M , et al . Cholesteryl ester transfer protein (CETP) as a drug target for cardiovascular disease . Nat Commun . 2021 ; 12 ( 1 ): 5640 .

Yu C , Bakshi A , Watts GF , Renton AE , Fulton-Howard B , Goate AM , et al . Genome-wide association study of cardiovascular resilience identifies protective variation in the CETP gene . J Am Heart Assoc . 2023 ; 12 ( 21 ): e031459 .

Piko P , Jenei T , Kosa Z , Sandor J , Kovacs N , Seres I , et al . Association of CETP gene polymorphisms and haplotypes with cardiovascular risk . Int J Mol Sci . 2023 ; 24 ( 12 ): 10281 .

Dunca D , Chopade S , Gordillo-Marañón M , Hingorani AD , Kuchenbaecker K , Finan C , et al . Comparing the effects of CETP in East Asian and European ancestries: a mendelian randomization study . Nat Commun . 2024 ; 15 ( 1 ): 5302 .

Staels B , Maes M , Zambon A . Fibrates and future PPARα agonists in the treatment of cardiovascular disease . Nat Clin Pract Cardiovasc Med . 2008 ; 5 ( 9 ): 542 - 53 .

Rajtar-Salwa R , Bobrowska B , Socha S , Dziewierz A , Siudak Z , Batko J , et al . Efficacy of alirocumab, evolocumab, and inclisiran in patients with hypercholesterolemia at increased cardiovascular risk . Medicina(Kaunas) . 2024 ; 60 ( 7 ): 1124 .

Mikhail N . Effects of evolocumab on cardiovascular events . Curr Cardiol Rev . 2017 ; 13 ( 4 ): 319 - 24 .

Ipsen DH , Lykkesfeldt J , Tveden-Nyborg P . Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease . Cell Mol Life Sci . 2018 ; 75 ( 18 ): 3313 - 27 .

Hu CQ , Hou T , Xiang R , Li X , Li J , Wang TT , et al . PANX1-mediated ATP release confers FAM3A’s suppression effects on hepatic gluconeogenesis and lipogenesis . Mil Med Res . 2024 ; 11 ( 1 ): 41 .

Miao GL , Zhang WX , Xu YT , Liu YR , Lai PP , Guo JB , et al . Motor protein KIF13B orchestrates hepatic metabolism to prevent metabolic dysfunction-associated fatty liver disease . Mil Med Res . 2025 ; 12 ( 1 ): 11 .

Yang M , Geng CA , Liu X , Guan M . Lipid disorders in NAFLD and chronic kidney disease . Biomedicines . 2021 ; 9 ( 10 ): 1405 .

Artru F , McPhail MJW , Triantafyllou E , Trovato FM . Lipids in liver failure syndromes: a focus on eicosanoids, specialized pro-resolving lipid mediators and lysophospholipids . Front Immunol . 2022 ; 13 : 867261 .

Rao G , Peng X , Li X , An K , He H , Fu X , et al . Unmasking the enigma of lipid metabolism in metabolic dysfunction-associated steatotic liver disease: from mechanism to the clinic . Front Med . 2023 ; 10 : 1294267 .

Kaye GL , Kruszynska YT , Harry DS , Heslop K , Johnston DG , McIntyre N . Lipid metabolism and insulin resistance in cirrhosis . J Hepatol . 1994 ; 20 ( 6 ): 782 - 91 .

Libby AE , Bales E , Orlicky DJ , McManaman JL . Perilipin-2 deletion impairs hepatic lipid accumulation by interfering with sterol regulatory element-binding protein (SREBP) activation and altering the hepatic lipidome . J Biol Chem . 2016 ; 291 ( 46 ): 24231 - 46 .

Morioka S , Sai K , Omori E , Ikeda Y , Matsumoto K , Ninomiya-Tsuji J . TAK1 regulates hepatic lipid homeostasis through SREBP . Oncogene . 2016 ; 35 ( 29 ): 3829 - 38 .

Lee SH , Lee J-H , Im S-S . The cellular function of SCAP in metabolic signaling . Exp Mol Med . 2020 ; 52 ( 5 ): 724 - 9 .

Chandrasekaran P , Weiskirchen R . The role of SCAP/SREBP as central regulators of lipid metabolism in hepatic steatosis . Int J Mol Sci . 2024 ; 25 ( 2 ): 1109 .

Buzzetti E , Pinzani M , Tsochatzis EA . The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD) . Metabolism . 2016 ; 65 ( 8 ): 1038 - 48 .

Mardinoglu A , Boren J , Smith U . Confounding effects of metformin on the human gut microbiome in type 2 diabetes . Cell Metab . 2016 ; 23 ( 1 ): 10 - 2 .

Li N , Li X , Ding Y , Liu X , Diggle K , Kisseleva T , et al . SREBP regulation of lipid metabolism in liver disease, and therapeutic strategies . Biomedicines . 2023 ; 11 ( 12 ): 3280 .

Dai M , Yang J , Xie M , Lin J , Luo M , Hua H , et al . Inhibition of JNK signalling mediates PPARα-dependent protection against intrahepatic cholestasis by fenofibrate . Br J Pharmacol . 2017 ; 174 ( 18 ): 3000 - 17 .

Pyrig LA , Melman N , Petrun NM , Nikulina GG , Gorelova NR . Abnormalities of lipid metabolism and methods of their correction in patients with glomerulonephritis . Int Urol Nephrol . 1984 ; 16 ( 4 ): 361 - 7 .

Hirano H , Yamada Y , Otani H , Kodama N , Mune M , Yukawa S . Evaluation of serum lipid abnormalities in chronic nephritis . Kidney Int Suppl . 1999 ; 71 : S147 - 9 .

Peng L , Wang C , Yu S , Li Q , Wu G , Lai W , et al . Dysregulated lipid metabolism is associated with kidney allograft fibrosis . Lipids Health Dis . 2024 ; 23 ( 1 ): 37 .

Chan MK . Lipid metabolism in renal failure . Clin Biochem . 1990 ; 23 ( 1 ): 61 - 5 .

Cheng R , Ding L , He X , Takahashi Y , Ma JX . Interaction of PPARα with the canonic Wnt pathway in the regulation of renal fibrosis . Diabetes . 2016 ; 65 ( 12 ): 3730 - 43 .

Wu J , Shao X , Shen J , Lin Q , Zhu X , Li S , et al . Downregulation of PPARα mediates FABP1 expression, contributing to IgA nephropathy by stimulating ferroptosis in human mesangial cells . Int J Biol Sci . 2022 ; 18 ( 14 ): 5438 - 58 .

Yuan T , Xia Y , Pan S , Li B , Ye Z , Yan X , et al . STAT6 promoting oxalate crystal deposition-induced renal fibrosis by mediating macrophage-to-myofibroblast transition via inhibiting fatty acid oxidation . Inflamm Res . 2023 ; 72 ( 12 ): 2111 - 26 .

Li J , Yang Y , Li Q , Wei S , Zhou Y , Yu W , et al . STAT6 contributes to renal fibrosis by modulating PPARα-mediated tubular fatty acid oxidation . Cell Death Dis . 2022 ; 13 ( 1 ): 66 .

Mitrofanova A , Merscher S , Fornoni A . Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease . Nat Rev Nephrol . 2023 ; 19 ( 10 ): 629 - 45 .

Yong W , Li Z , Xu W , Gao D , Sha B , Jin Y , et al . Quercetin ameliorates renal injury by promoting UCP1-mediated alleviation of lipid accumulation in diabetic kidney disease . Phytomedicine . 2025 ; 147 : 157213 .

Zhao M , Yuan H , Yang G , Wang Y , Bu Y , Zhang H , et al . Tumour cell-expressed PD-L1 reprograms lipid metabolism via EGFR/ITGB4/SREBP1c signalling in liver cancer . JHEP Rep . 2024 ; 6 ( 4 ): 101009 .

Wang X , Li Y , Hou X , Li J , Ma X . Lipid metabolism reprogramming in endometrial cancer: biological functions and therapeutic implications . Cell Commun Signal . 2024 ; 22 ( 1 ): 436 .

Piccinin E , Cariello M , Moschetta A . Lipid metabolism in colon cancer: role of liver X receptor (LXR) and stearoyl-CoA desaturase 1 (SCD1) . Mol Aspects Med . 2021 ; 78 : 100933 .

Blücher C , Iberl S , Schwagarus N , Müller S , Liebisch G , Höring M , et al . Secreted factors from adipose tissue reprogram tumor lipid metabolism and induce motility by modulating PPARα/ANGPTL4 and FAK . Mol Cancer Res . 2020 ; 18 ( 12 ): 1849 - 62 .

Zhang J , Song Y , Shi Q , Fu L . Research progress on FASN and MGLL in the regulation of abnormal lipid metabolism and the relationship between tumor invasion and metastasis . Front Med . 2021 ; 15 ( 5 ): 649 - 56 .

Rajasekaran D , Jariwala N , Mendoza RG , Robertson CL , Akiel MA , Dozmorov M , et al . Staphylococcal nuclease and tudor domain containing 1 (SND1 protein) promotes hepatocarcinogenesis by inhibiting monoglyceride lipase (MGLL) . J Biol Chem . 2016 ; 291 ( 20 ): 10736 - 46 .

Cao S , Saw PE , Shen Q , Li R , Liu Y , Xu X . Reduction-responsive RNAi nanoplatform to reprogram tumor lipid metabolism and repolarize macrophage for combination pancreatic cancer therapy . Biomaterials . 2022 ; 280 : 121264 .

Siddiqui S , Glauben R . Fatty acid metabolism in myeloid-derived suppressor cells and tumor-associated macrophages: key factor in cancer immune evasion . Cancers . 2022 ; 14 ( 1 ): 250 .

Li Y , Kasim V , Yan X , Li L , Meliala ITS , Huang C , et al . Yin Yang 1 facilitates hepatocellular carcinoma cell lipid metabolism and tumor progression by inhibiting PGC-1β-induced fatty acid oxidation . Theranostics . 2019 ; 9 ( 25 ): 7599 - 615 .

Morales A , Greenberg M , Nardi F , Gil V , Hayward SW , Crawford SE , et al . Loss of ephrin B2 receptor (EPHB2) sets lipid rheostat by regulating proteins DGAT1 and ATGL inducing lipid droplet storage in prostate cancer cells . Lab Invest . 2021 ; 101 ( 7 ): 921 - 34 .

Senga S , Kobayashi N , Kawaguchi K , Ando A , Fujii H . Fatty acid-binding protein 5 (FABP5) promotes lipolysis of lipid droplets, de novo fatty acid(FA) synthesis and activation of nuclear factor-kappa B (NF-κB) signaling in cancer cells . Biochimica et Biophys Acta (BBA) . 2018 ; 1863 ( 9 ): 1057 - 67 .

Crunkhorn S . Breast cancer: inhibiting fatty acid oxidation blocks tumour growth . Nat Rev Drug Discov . 2016 ; 15 ( 5 ): 310 .

Guo X , Wang A , Wang W , Wang Y , Chen H , Liu X , et al . HRD1 inhibits fatty acid oxidation and tumorigenesis by ubiquitinating CPT2 in triple-negative breast cancer . Mol Oncol . 2020 ; 15 ( 2 ): 642 - 56 .

Wang J , He Y , Hu F , Hu C , Sun Y , Yang K , et al . Metabolic reprogramming of immune cells in the tumor microenvironment . Int J Mol Sci . 2024 ; 25 ( 22 ): 12223 .

Lim SA , Wei J , Nguyen T-LM , Shi H , Su W , Palacios G , et al . Lipid signalling enforces functional specialization of Treg cells in tumours . Nature . 2021 ; 591 ( 7849 ): 306 - 11 .

Luo M , Yan J , Hu X , Li H , Li H , Liu Q , et al . Targeting lipid metabolism for ferroptotic cancer therapy . Apoptosis . 2023 ; 28 ( 1 ): 81 - 107 .

Zhang L , Chang N , Liu J , Liu Z , Wu Y , Sui L , et al . Reprogramming lipid metabolism as potential strategy for hematological malignancy therapy . Front Oncol . 2022 ; 12 : 987499 .

Liu X , Hartman CL , Li L , Albert CJ , Si F , Gao A , et al . Reprogramming lipid metabolism prevents effector T cell senescence and enhances tumor immunotherapy . Sci Transl Med . 2021 ; 13 ( 587 ): eaaz6314 .

Kao YC , Ho PC , Tu YK , Jou IM , Tsai KJ . Lipids and Alzheimer’s disease . Int J Mol Sci . 2020 ; 21 ( 4 ): 1505 .

Qiu J , Wei L , Su Y , Tang Y , Peng G , Wu Y , et al . Lipid metabolism disorder in cerebrospinal fluid related to Parkinson’s disease . Brain Sci . 2023 ; 13 ( 8 ): 1505 .

Sinclair E , Trivedi DK , Sarkar D , Walton-Doyle C , Milne J , Kunath T , et al . Metabolomics of sebum reveals lipid dysregulation in Parkinson’s disease . Nat Commun . 2021 ; 12 ( 1 ): 1592 .

Korshoj LE , Kielian T . Neuroimmune metabolism: uncovering the role of metabolic reprogramming in central nervous system disease . J Neurochem . 2021 ; 158 ( 1 ): 8 - 13 .

Gu L , Ju Y , Hu M , Zheng M , Li Q , Zhang X . Research progress of PPARγ regulation of cholesterol and inflammation in Alzheimer’s disease . Metab Brain Dis . 2023 ; 38 ( 3 ): 839 - 54 .

Jaafar AK , Techer R , Chemello K , Lambert G , Bourane S . PCSK9 and the nervous system: A no-brainer? . J Lipid Res . 2023 ; 64 ( 9 ): 100426 .

Jaafar AK , Paulo-Ramos A , Rastoldo G , Veeren B , Planesse C , Bringart M , et al . PCSK9 deficiency promotes the development of peripheral neuropathy . JCI Insight . 2024 ; 10 ( 12 ): e183786 .

Kingwell K . Targeting glial lipid metabolism to tackle neurodegeneration . Nat Rev Drug Discov . 2024 ; 23 ( 2 ): 106 .

Munro D , Blier PU . The extreme longevity of Arctica islandica is associated with increased peroxidation resistance in mitochondrial membranes . Aging Cell . 2012 ; 11 ( 5 ): 845 - 55 .

Rabini RA , Moretti N , Staffolani R , Salvolini E , Nanetti L , Franceschi C , et al . Reduced susceptibility to peroxidation of erythrocyte plasma membranes from centenarians . Exp Gerontol . 2002 ; 37 ( 5 ): 657 - 63 .

Mutlu AS , Duffy J , Wang MC . Lipid metabolism and lipid signals in aging and longevity . Dev Cell . 2021 ; 56 ( 10 ): 1394 - 407 .

Cadenas C , Vosbeck S , Hein EM , Hellwig B , Langer A , Hayen H , et al . Glycerophospholipid profile in oncogene-induced senescence . Biochim Biophys Acta . 2012 ; 1821 ( 9 ): 1256 - 68 .

Zeng Q , Gong Y , Zhu N , Shi Y , Zhang C , Qin L . Lipids and lipid metabolism in cellular senescence: emerging targets for age-related diseases . Ageing Res Rev . 2024 ; 97 : 102294 .

Chen Y , Wang Y , Huang Y , Zeng H , Hu B , Guan L , et al . PPARα regulates tumor cell proliferation and senescence via a novel target gene carnitine palmitoyltransferase 1C . Carcinogenesis . 2017 ; 38 ( 4 ): 474 - 83 .

Ernszt D , Banfai K , Kellermayer Z , Pap A , Lord JM , Pongracz JE , et al . PPARgamma deficiency counteracts thymic senescence . Front Immunol . 2017 ; 8 : 1515 .

Ishida CT , Myers SL , Shao W , McGuire MR , Liu C , Kubota CS , et al . SREBP-dependent regulation of lipid homeostasis is required for progression and growth of pancreatic ductal adenocarcinoma . Cancer Res Commun . 2024 ; 4 ( 9 ): 2539 - 52 .

Yang S , Liu C , Jiang M , Liu X , Geng L , Zhang Y , et al . A single-nucleus transcriptomic atlas of primate liver aging uncovers the pro-senescence role of SREBP2 in hepatocytes . Protein Cell . 2024 ; 15 ( 2 ): 98 - 120 .

Admasu TD , Chaithanya Batchu K , Barardo D , Ng LF , Lam VYM , Xiao L , et al . Drug synergy slows aging and improves healthspan through IGF and SREBP lipid signaling . Dev Cell . 2018 ; 47 ( 1 ): 67 - 79.e5 .

Zhang J , Hu W , Zou Z , Li Y , Kang F , Li J , et al . The role of lipid metabolism in osteoporosis: clinical implication and cellular mechanism . Genes Dis . 2023 ; 11 ( 4 ): 101122 .

Wang Y , Zeng T , Tang D , Cui H , Wan Y , Tang H . Integrated multi-omics analyses reveal lipid metabolic signature in osteoarthritis . J Mol Biol . 2025 ; 437 ( 6 ): 168888 .

An F , Jia X , Shi Y , Xiao X , Yang F , Su J , et al . The ultimate microbial composition for correcting Th17/Treg cell imbalance and lipid metabolism disorders in osteoporosis . Int Immunopharmacol . 2025 ; 144 : 113613 .

Runyan CE , Liu Z , Schnaper HW . Phosphatidylinositol 3-kinase and Rab5 GTPase inversely regulate the Smad anchor for receptor activation (SARA) protein independently of transforming growth factor-β1 . J Biol Chem . 2012 ; 287 ( 43 ): 35815 - 24 .

Kostopoulou F , Gkretsi V , Malizos KN , Iliopoulos D , Oikonomou P , Poultsides L , et al . Central role of SREBP-2 in the pathogenesis of osteoarthritis . PLoS One . 2012 ; 7 ( 5 ): e35753 .

Inoue K , Imai Y . Fatostatin, an SREBP inhibitor, prevented RANKL-induced bone loss by suppression of osteoclast differentiation . Biochim Biophys Acta . 2015 ; 1852 ( 11 ): 2432 - 41 .

Han X . Lipidomics for studying metabolism . Nat Rev Endocrinol . 2016 ; 12 ( 11 ): 668 - 79 .

Wen D , Wang J , Van Den Driessche G , Chen Q , Zhang Y , Chen G , et al . Adipocytes as anticancer drug delivery depot . Matter . 2019 ; 1 ( 5 ): 1203 - 14 .

Li B , Zhang Q , Cheng J , Feng Y , Jiang L , Zhao X , et al . A nanocapsule system combats aging by inhibiting age-related angiogenesis deficiency and glucolipid metabolism disorders . ACS Nano . 2024 ; 18 ( 32 ): 21061 - 76 .

Xu H , She P , Zhao Z , Ma B , Li G , Wang Y . Duplex responsive nano-platform with cascade targeting for atherosclerosis photoacoustic diagnosis and multichannel combination therapy . Adv Mater . 2023 ; 35 ( 21 ): e2300439 .

Liang J , Shao W , Ni P , Liu Q , Kong W , Shen W , et al . siRNA/CS-PLGA nanoparticle system targeting knockdown intestinal SOAT2 reduced intestinal lipid uptake and alleviated obesity . Adv Sci . 2024 ; 11 ( 40 ): e2403442 .

Wang Y , Calvert AE , Cardenas H , Rink JS , Nahotko D , Qiang W , et al . Nanoparticle targeting in chemo-resistant ovarian cancer reveals dual axis of therapeutic vulnerability involving cholesterol uptake and cell redox balance . Adv Sci . 2024 ; 11 ( 13 ): e2305212 .

Wan Q , Huang B , Li T , Xiao Y , He Y , Du W , et al . Selective targeting of visceral adiposity by polycation nanomedicine . Nat Nanotechnol . 2022 ; 17 ( 12 ): 1311 - 21 .

Wu C , Xiang S , Wang H , Zhang X , Tian X , Tan M , et al . Orally deliverable sequence-targeted fucoxanthin-loaded biomimetic extracellular vesicles for alleviation of nonalcoholic fatty liver disease . ACS Appl Mater Interfaces . 2024 ; 16 ( 8 ): 9854 - 67 .

Yao X , Xie R , Cao Y , Tang J , Men Y , Peng H , et al . Simvastatin induced ferroptosis for triple-negative breast cancer therapy . J Nanobiotechnology . 2021 ; 19 ( 1 ): 311 .

Liu X , Zhao Z , Sun X , Wang J , Yi W , Wang D , et al . Blocking cholesterol metabolism with tumor-penetrable nanovesicles to improve photodynamic cancer immunotherapy . Small Methods . 2023 ; 7 ( 5 ): e2200898 .

Luo J , Shang Y , Zhao N , Lu X , Wang Z , Li X , et al . Hypoxia-responsive micelles deprive cofactor of stearoyl-CoA desaturase-1 and sensitize ferroptotic ovarian cancer therapy . Biomaterials . 2025 ; 314 : 122820 .

Wu S , Wang J , Fu Z , Familiari G , Relucenti M , Aschner M , et al . Matairesinol nanoparticles restore chemosensitivity and suppress colorectal cancer progression in preclinical models: role of lipid metabolism reprogramming . Nano Lett . 2023 ; 23 ( 5 ): 1970 - 80 .

Xu X , Deng G , Sun Z , Luo Y , Liu J , Yu X , et al . A biomimetic aggregation-induced emission photosensitizer with antigen-presenting and hitchhiking function for lipid droplet targeted photodynamic immunotherapy . Adv Mater . 2021 ; 33 ( 33 ): e2102322 .

Lee MMS , Lin DM , Chau JHC , Yu EY , Ding D , Kwok RTK , et al . Adipocyte-targeting type I AIE photosensitizer for obesity treatment via photodynamic lipid peroxidation . ACS Nano . 2023 ; 17 ( 11 ): 11039 - 53 .

Liang T , Wen D , Chen G , Chan A , Chen Z , Li H , et al . Adipocyte-derived anticancer lipid droplets . Adv Mater . 2021 ; 33 ( 26 ): e2100629 .

Wang J , Zhang T , Gu R , Ke Y , Zhang S , Su X , et al . Development and evaluation of reconstructed nanovesicles from turmeric for multifaceted obesity intervention . ACS Nano . 2024 ; 18 ( 34 ): 23117 - 35 .

Pan S , Yang X , Jia Y , Li Y , Chen R , Wang M , et al . Intravenous injection of microvesicle-delivery miR-130b alleviates high-fat diet-induced obesity in C57BL/6 mice through translational repression of PPAR-γ . J Biomed Sci . 2015 ; 22 : 86 .

Zhang LF , Deng WQ , Huang QW , Zhang JJ , Wang Y , Zhou TJ , et al . Vicious cycle-breaking lipid nanoparticles remodeling multicellular crosstalk to reverse liver fibrosis . Adv Mater . 2024 ; 36 ( 16 ): e2311474 .

Wang D , Pan Y , Chen W , He D , Qi W , Chen J , et al . Nanodrugs targeting key factors of ferroptosis regulation for enhanced treatment of osteoarthritis . Adv Sci . 2025 ; 12 ( 11 ): e2412817 .

Cai J , Peng J , Feng J , Li R , Ren P , Zang X , et al . Antioxidant hepatic lipid metabolism can be promoted by orally administered inorganic nanoparticles . Nat Commun . 2023 ; 14 ( 1 ): 3643 .

Zhou W , Lew B , Choi H , Kim K , Anakk S . Chenodeoxycholic acid-loaded nanoparticles are sufficient to decrease adipocyte size by inducing mitochondrial function . Nano Lett . 2024 ; 24 ( 5 ): 1642 - 9 .

Du B , Zheng M , Ma H , Huang J , Jiao Q , Bai Y , et al . Nanozyme-natural enzymes cascade catalyze cholesterol consumption and reverse cancer multidrug resistance . J Nanobiotechnology . 2022 ; 20 ( 1 ): 209 .

Zhang P , Shi Y , Xu Y , Liang Y , Huang C , Zhong D , et al . A nano-autophagy inhibitor triggering reciprocal feedback control of cholesterol depletion for solid tumor therapy . Adv Healthc Mater . 2023 ; 12 ( 32 ): e2302020 .

Shen L , Yang Z , Zhong Y , Bi Y , Yu J , Lu Q , et al . Cholesterol targeted catalytic hydrogel fueled by tumor debris can enhance microwave ablation therapy and anti-tumor immune response . Adv Sci . 2025 ; 12 ( 5 ): e2406975 .

Xie S , Sun W , Zhang C , Dong B , Yang J , Hou M , et al . Metabolic control by heat stress determining cell fate to ferroptosis for effective cancer therapy . ACS Nano . 2021 ; 15 ( 4 ): 7179 - 94 .

Qin YT , Liu XH , An JX , Liang JL , Li CX , Jin XK , et al . Dendritic cell-based in situ nanovaccine for reprogramming lipid metabolism to boost tumor immunotherapy . ACS Nano . 2023 ; 17 ( 24 ): 24947 - 60 .

Kim D , Wu Y , Li Q , Oh YK . Nanoparticle-mediated lipid metabolic reprogramming of T cells in tumor microenvironments for immunometabolic therapy . Nano-Micro Lett . 2021 ; 13 ( 1 ): 31 .

Deng C , Xiao Y , Zhao X , Li H , Chen Y , Ai K , et al . Sequential targeting chondroitin sulfate-bilirubin nanomedicine attenuates osteoarthritis via reprogramming lipid metabolism in M1 macrophages . Adv Sci . 2025 ; 12 ( 9 ): e2411911 .

Wang H , Su S , An X , Xu Y , Sun J , Zhen M , et al . A charge reversal nano-assembly prevents hepatic steatosis by resolving inflammation and improving lipid metabolism . Bioact Mater . 2024 ; 45 : 496 - 508 .

Liu Q , Mei J , Wang Z , Zhang X , Hu X , Xu D , et al . Nano-fat actuated lipo-metabolic reprogramming of macrophages for intracellular infections in biofilm microenvironment . Adv Funct Mater . 2024 ; 34 ( 44 ): 2405852 .

Ma J , Guo D , Ji X , Zhou Y , Liu C , Li Q , et al . Composite hydrogel for spatiotemporal lipid intervention of tumor milieu . Adv Mater . 2023 ; 35 ( 14 ): e2211579 .

Xu S , Chaudhary O , Rodríguez-Morales P , Sun X , Chen D , Zappasodi R , et al . Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8(+) T cells in tumors . Immunity . 2021 ; 54 ( 7 ): 1561 - 77.e7 .

Guo S , Lu J , Zhuo Y , Xiao M , Xue X , Zhong S , et al . Endogenous cholesterol ester hydroperoxides modulate cholesterol levels and inhibit cholesterol uptake in hepatocytes and macrophages . Redox Biol . 2019 ; 21 : 101069 .

Morigny P , Boucher J , Arner P , Langin D . Lipid and glucose metabolism in white adipocytes: pathways, dysfunction and therapeutics . Nat Rev Endocrinol . 2021 ; 17 ( 5 ): 276 - 95 .

Griffin JD , Buxton JM , Culver JA , Barnes R , Jordan EA , White AR , et al . Hepatic activin E mediates liver-adipose inter-organ communication, suppressing adipose lipolysis in response to elevated serum fatty acids . Mol Metab . 2023 ; 78 : 101830 .

Wang L , Li X , Hu X , Chen S , Qiu Z , Wang Y , et al . Grain boundary boosting the thermal stability of Pt/CeO2 thin films . Nano Res . 2022 ; 16 ( 2 ): 3278 - 86 .

Chen J , Yin T , Hu X , Chang L , Sang Y , Xu L , et al . CD36-mediated arachidonic acid influx from decidual stromal cells increases inflammatory macrophages in miscarriage . Cell Rep . 2024 ; 43 ( 11 ): 114881 .

Yang P , Qin H , Li Y , Xiao A , Zheng E , Zeng H , et al . CD36-mediated metabolic crosstalk between tumor cells and macrophages affects liver metastasis . Nat Commun . 2022 ; 13 ( 1 ): 5782 .

Shu H , Peng Y , Hang W , Nie J , Zhou N , Wang DW . The role of CD36 in cardiovascular disease . Cardiovasc Res . 2022 ; 118 ( 1 ): 115 - 29 .

Xu H , She P , Ma B , Zhao Z , Li G , Wang Y . ROS responsive nanoparticles loaded with lipid-specific AIEgen for atherosclerosis-targeted diagnosis and bifunctional therapy . Biomaterials . 2022 ; 288 : 121734 .

Sousa AR , Oliveira MJ , Sarmento B . Impact of CEA-targeting nanoparticles for drug delivery in colorectal cancer . J Pharmacol Exp Ther . 2019 ; 370 ( 3 ): 657 - 70 .

Zhang J , Kelley KL , Marshall SM , Davis MA , Wilson MD , Sawyer JK , et al . Tissue-specific knockouts of ACAT2 reveal that intestinal depletion is sufficient to prevent diet-induced cholesterol accumulation in the liver and blood . J Lipid Res . 2012 ; 53 ( 6 ): 1144 - 52 .

Tandon P , Wafer R , Minchin JEN . Adipose morphology and metabolic disease . J Exp Biol . 2018 ; 221 ( 1 ): jeb164970 .

Acosta JR , Douagi I , Andersson DP , Backdahl J , Ryden M , Arner P , et al . Increased fat cell size: a major phenotype of subcutaneous white adipose tissue in non-obese individuals with type 2 diabetes . Diabetologia . 2016 ; 59 ( 3 ): 560 - 70 .

Zeng J , Zhang Y , Ruan J , Yang Z , Wang C , Hong Z , et al . Protective effects of fucoxanthin and fucoxanthinol against tributyltin-induced oxidative stress in HepG2 cells . Environ Sci Pollut Res . 2018 ; 25 ( 6 ): 5582 - 9 .

Friedmann Angeli JP , Schneider M , Proneth B , Tyurina YY , Tyurin VA , Hammond VJ , et al . Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice . Nat Cell Biol . 2014 ; 16 ( 12 ): 1180 - 91 .

Geng F , Cheng X , Wu X , Yoo JY , Cheng C , Guo JY , et al . Inhibition of SOAT1 suppresses glioblastoma growth via blocking SREBP-1-mediated lipogenesis . Clin Cancer Res . 2016 ; 22 ( 21 ): 5337 - 48 .

Yang W , Bai Y , Xiong Y , Zhang J , Chen S , Zheng X , et al . Potentiating the antitumour response of CD8 + T cells by modulating cholesterol metabolism . Nature . 2016 ; 531 ( 7596 ): 651 - 5 .

Ning Z , Guo X , Liu X , Lu C , Wang A , Wang X , et al . USP22 regulates lipidome accumulation by stabilizing PPARγ in hepatocellular carcinoma . Nat Commun . 2022 ; 13 ( 1 ): 2187 .

Zhao P , Zhao Z , Yu Z , Chen L , Jin Y , Wu J , et al . Application of synthetic lipid droplets in metabolic diseases . Clin Transl Med . 2023 ; 13 ( 11 ): e1441 .

Bosch M , Sánchez-Álvarez M , Fajardo A , Kapetanovic R , Steiner B , Dutra F , et al . Mammalian lipid droplets are innate immune hubs integrating cell metabolism and host defense . Science . 2020 ; 370 ( 6514 ): eaay8085 .

Olzmann JA , Carvalho P . Dynamics and functions of lipid droplets . Nat Rev Mol Cell Biol . 2019 ; 20 ( 3 ): 137 - 55 .

Fujimoto T , Parton RG . Not just fat: the structure and function of the lipid droplet . Cold Spring Harb Perspect Biol . 2011 ; 3 ( 3 ): a004838 .

Su X , Peng D . The exchangeable apolipoproteins in lipid metabolism and obesity . Clin Chim Acta . 2020 ; 503 : 128 - 35 .

Sibuyi NRS , Moabelo KL , Meyer M , Onani MO , Dube A , Madiehe AM . Nanotechnology advances towards development of targeted-treatment for obesity . J Nanobiotechnology . 2019 ; 17 ( 1 ): 122 .

Janani C , Ranjitha Kumari BD . PPAR gamma gene--a review . Diabetes Metab Syndr . 2015 ; 9 ( 1 ): 46 - 50 .

Böhm F , Köhler UA , Speicher T , Werner S . Regulation of liver regeneration by growth factors and cytokines . EMBO Mol Med . 2010 ; 2 ( 8 ): 294 - 305 .

Xiao Y , Batmanov K , Hu W , Zhu K , Tom AY , Guan D , et al . Hepatocytes demarcated by EphB2 contribute to the progression of nonalcoholic steatohepatitis . Sci Transl Med . 2023 ; 15 ( 682 ): eadc9653 .

Fendt SM , Lunt SY . Dynamic ROS regulation by TIGAR: balancing anticancer and pro-metastasis effects . Cancer Cell . 2020 ; 37 ( 2 ): 141 - 2 .

Zhang Y , Zhang Y , Liang R , Zou J , Pei R , Chen X . Targeted ROS scavenging for disease therapies using nanomaterials . Adv Mater . 2025 : e04435 .

Gracia-Sancho J , Caparrós E , Fernández-Iglesias A , Frances R . Role of liver sinusoidal endothelial cells in liver diseases . Nat Rev Gastroenterol Hepatol . 2021 ; 18 ( 6 ): 411 - 31 .

Lian J , Nelson R , Lehner R . Carboxylesterases in lipid metabolism: from mouse to human . Protein Cell . 2018 ; 9 ( 2 ): 178 - 95 .

Wang H , Chen J , Hollister K , Sowers LC , Forman BM . Endogenous bile acids are ligands for the nuclear receptor FXR/BAR . Mol Cell . 1999 ; 3 ( 5 ): 543 - 53 .

Kawamata Y , Fujii R , Hosoya M , Harada M , Yoshida H , Miwa M , et al . A G protein-coupled receptor responsive to bile acids . J Biol Chem . 2003 ; 278 ( 11 ): 9435 - 40 .

Xie H , Simon MC . Oxygen availability and metabolic reprogramming in cancer . J Biol Chem . 2017 ; 292 ( 41 ): 16825 - 32 .

Xu T , Ma Y , Yuan Q , Hu H , Hu X , Qian Z , et al . Enhanced ferroptosis by oxygen-boosted phototherapy based on a 2-in-1 nanoplatform of ferrous hemoglobin for tumor synergistic therapy . ACS Nano . 2020 ; 14 ( 3 ): 3414 - 25 .

Xu C , Ji X , Zhou Y , Cheng Y , Guo D , Li Q , et al . Slimming and reinvigorating tumor-associated dendritic cells with hierarchical lipid rewiring nanoparticles . Adv Mater . 2023 ; 35 ( 30 ): e2211415 .

Binnewies M , Roberts EW , Kersten K , Chan V , Fearon DF , Merad M , et al . Understanding the tumor immune microenvironment (TIME) for effective therapy . Nat Med . 2018 ; 24 ( 5 ): 541 - 50 .

Jin R , Neufeld L , McGaha TL . Linking macrophage metabolism to function in the tumor microenvironment . Nat Cancer . 2025 ; 6 ( 2 ): 239 - 52 .

Sun Z , Liu Q , Lv Z , Li J , Xu X , Sun H , et al . Targeting macrophagic SHP2 for ameliorating osteoarthritis via TLR signaling . Acta Pharm Sin B . 2022 ; 12 ( 7 ): 3073 - 84 .

Jeelani I , Moon JS , da Cunha FF , Nasamran CA , Jeon S , Zhang X , et al . HIF-2α drives hepatic Kupffer cell death and proinflammatory recruited macrophage activation in nonalcoholic steatohepatitis . Sci Transl Med . 2024 ; 16 ( 764 ): eadi0284 .

Fang C , Zhong R , Lu S , Yu G , Liu Z , Yan C , et al . TREM2 promotes macrophage polarization from M1 to M2 and suppresses osteoarthritis through the NF-κB/CXCL3 axis . Int J Biol Sci . 2024 ; 20 ( 6 ): 1992 - 2007 .

Costerton JW , Stewart PS , Greenberg EP . Bacterial biofilms: a common cause of persistent infections . Science . 1999 ; 284 ( 5418 ): 1318 - 22 .

Kroemer G , Galassi C , Zitvogel L , Galluzzi L . Immunogenic cell stress and death . Nat Immunol . 2022 ; 23 ( 4 ): 487 - 500 .

Hadjidemetriou M , Kostarelos K . Nanomedicine: evolution of the nanoparticle corona . Nat Nanotechnol . 2017 ; 12 ( 4 ): 288 - 90 .

Lu M , Gursky O . Aggregation and fusion of low-density lipoproteins in vivo and in vitro . Biomol Concepts . 2013 ; 4 ( 5 ): 501 - 18 .

Wu J , Bai X , Yan L , Baimanov D , Cong Y , Quan P , et al . Selective regulation of macrophage lipid metabolism via nanomaterials’ surface chemistry . Nat Commun . 2024 ; 15 ( 1 ): 8349 .

Clària J , Curto A , Moreau R , Colsch B , Lopez-Vicario C , Lozano JJ , et al . Untargeted lipidomics uncovers lipid signatures that distinguish severe from moderate forms of acutely decompensated cirrhosis . J Hepatol . 2021 ; 75 ( 5 ): 1116 - 27 .

Su X , Peng D . New insight into sortilin in controlling lipid metabolism and the risk of atherogenesis . Biol Rev Camb Philos Soc . 2020 ; 95 ( 1 ): 232 - 43 .

Cao Y . Adipocyte and lipid metabolism in cancer drug resistance . J Clin Invest . 2019 ; 129 ( 8 ): 3006 - 17 .

Yang Y , Yang L , Wang Y . [Immunotherapy for lung cancer: mechanisms of resistance and response strategy] . Zhongguo Fei Ai Za Zhi . 2021 ; 24 ( 2 ): 112 - 23 .

Pope LE , Dixon SJ . Regulation of ferroptosis by lipid metabolism . Trends Cell Biol . 2023 ; 33 ( 12 ): 1077 - 87 .

Barrera G , Pizzimenti S , Dianzani MU . Lipid peroxidation: control of cell proliferation, cell differentiation and cell death . Mol Aspects Med . 2008 ; 29 ( 1-2 ): 1 - 8 .

Zheng J , Conrad M . The metabolic underpinnings of ferroptosis . Cell Metab . 2020 ; 32 ( 6 ): 920 - 37 .

Wu J , Zhang X , Sun D , Shi X , Sun J , Luo C , et al . Molecularly engineering a lipid nanoregulator destroying the last defense of ferroptosis in breast cancer therapy . Chem Eng J . 2024 ; 495 : 153366 .

Chen Q , Sun Y , Wang S , Xu J . New prospects of cancer therapy based on pyroptosis and pyroptosis inducers . Apoptosis . 2024 ; 29 ( 1-2 ): 66 - 85 .

Zhou J , Ji J , Li X , Zhang Y , Gu L , Zheng X , et al . Homomultivalent polymeric nanotraps disturb lipid metabolism homeostasis and tune pyroptosis in cancer . Adv Mater . 2024 ; 36 ( 15 ): e2312528 .

Declercq HA , de Caluwé T , Krysko O , Bachert C , Cornelissen MJ . Bone grafts engineered from human adipose-derived stem cells in dynamic 3D-environments . Biomaterials . 2013 ; 34 ( 4 ): 1004 - 17 .

Nie T , Deng W , Gao X , Sun W , Hui X , Song H , et al . Reprogramming mature terminally differentiated adipocytes to induced pluripotent stem cells . Sci Bull . 2015 ; 60 ( 20 ): 1752 - 8 .

Khirallah J , Eimbinder M , Li Y , Xu Q . Clinical progress in genome-editing technology and in vivo delivery techniques . Trends Genet . 2023 ; 39 ( 3 ): 208 - 16 .

Dash PK , Kevadiya BD , Su H , Banoub MG , Gendelman HE . Pathways towards human immunodeficiency virus elimination . EBioMedicine . 2020 ; 53 : 102667 .

Lee J , Kweon J , Kim Y . Emerging trends in prime editing for precision genome editing . Exp Mol Med . 2025 ; 57 ( 7 ): 1381 - 91 .

Nguyen HP , An K , Ito Y , Kharbikar BN , Sheng R , Paredes B , et al . Implantation of engineered adipocytes suppresses tumor progression in cancer models . Nat Biotechnol . 2025 .